Today’s top gainers include the company Merck & Co. Inc. (NYSE:MRK) which is in the industry Drug Manufacturers – Major, gaining -1.11% today. In the last week its performance is -1.36%, and 4.51% for the past quarter. Currently, Merck & Co. Inc., MRK has a target price of 61.85, so today’s gain of -1.11% is a significant step towards its target price. The GAP today is therefore 0.10%.
Merck & Co. Inc. (NYSE:MRK), has a market cap of 163166.68, and is based in USA. Insider ownership is at 0.04%, and institutional ownership is 74.90%.
At the current price of 58.17, it has a dividend yield of 3.13%, and its target price is 61.85. This is with a profit margin of 11.70%, and total debt/equity of 0.59. Merck & Co. Inc. (NYSE:MRK) has a P/E of 35.98, as well as a forward P/E of 15.69.
With a current EPS of 1.64, and a forecasted EPS growth for next year at 0.81%,Merck & Co. Inc. (NYSE:MRK) has had a EPS growth for the past five years at 41.50%. For the next five years EPS growth is projected to be 5.10%.
Performance for the year is 4.80%. Since its IPO date on 1/2/1970, the total performance to date is 13.25%.
Volume today for Merck & Co. Inc. (NYSE:MRK), is 3930452, while its average volume is 8826.07. Whilst the total gain today was -1.11%, it did have a day high of -2.97%.
Volatility for this week has been at 1.07%, and 1.21% for the month. The 52-week low for Merck & Co. Inc., MRK has been 31.72%, while the 52-week-high has reached -2.97%.
Looking at its return of investments, which is 6.40%, and its return on assets is 4.60%. Merck & Co. Inc. (NYSE:MRK) has an operating margin of 18.20%. With a sales growth of -1.20% quarter over quarter. Bearing in mind that Merck & Co. Inc., MRK is in the sector Healthcare, its long-term debt/equity is 0.54, and has a current ratio of 1.6 and 1.3 for quick ratio.
So what is the value of Merck & Co. Inc.? Well its PEG is 7.06, and the P/S is 4.14, along with a P/B of 3.73. Meanwhile it has a p/cash of 12.61.